Ledger.Open graph →
SEC Form D · Amendment · filed January 21, 2021

Virion Therapeutics, LLC

Offering
$6.0M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWARK, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Andrew Luber · Newark, DEExec · DirectorBernard Rudnick · Newark, DEExec · DirectorEric Sackowitz · Norwalk, CTExec · DirectorAlexander Harrington · New York, NYExec · DirectorVirtus Real Estate Capital EC Management GP, LLC · Austin, TXExec · DirectorWilliam Strong · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗